These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 22566174)
21. A simple method for the detection of insoluble aggregates in protein formulations. Li B; Flores J; Corvari V J Pharm Sci; 2007 Jul; 96(7):1840-3. PubMed ID: 17299781 [TBL] [Abstract][Full Text] [Related]
29. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach. Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404 [TBL] [Abstract][Full Text] [Related]
30. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution. Nayak A; Colandene J; Bradford V; Perkins M J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601 [TBL] [Abstract][Full Text] [Related]
31. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs). Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896 [TBL] [Abstract][Full Text] [Related]
32. Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations. Ludwig DB; Trotter JT; Gabrielson JP; Carpenter JF; Randolph TW Anal Biochem; 2011 Mar; 410(2):191-9. PubMed ID: 21146492 [TBL] [Abstract][Full Text] [Related]
34. Differential scanning fluorimetry: rapid screening of formulations that promote the stability of reference preparations. Malik K; Matejtschuk P; Thelwell C; Burns CJ J Pharm Biomed Anal; 2013 Apr; 77():163-6. PubMed ID: 23416371 [TBL] [Abstract][Full Text] [Related]
35. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags. Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600 [TBL] [Abstract][Full Text] [Related]
36. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. Singh SK; Afonina N; Awwad M; Bechtold-Peters K; Blue JT; Chou D; Cromwell M; Krause HJ; Mahler HC; Meyer BK; Narhi L; Nesta DP; Spitznagel T J Pharm Sci; 2010 Aug; 99(8):3302-21. PubMed ID: 20310025 [TBL] [Abstract][Full Text] [Related]